Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in ...
Check out our curated selection of the best fitness trackers currently available on the market to help you reach your health ...
India Today on MSN
Holiday stress and stroke risk: Why mental and physical strain matters
Holiday stress, late nights, rich food and missed medicines can quietly raise stroke risk. Neurologists warn that recognising ...
Healthcare in 2025 saw rapid innovation, rising costs, ACA subsidy expiration, AI adoption, consolidation, and affordability ...
Contemporary cardiology faces a paradox: unprecedented technological capability coincides with declining scientific curiosity ...
News-Medical.Net on MSN
Imaging-enhanced knowledge graphs reveal new targets for heart disease treatment
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
MedPage Today on MSN
Pulsed Field Ablation Safety Issues: Will Newer Devices Clear the Stumbling Block?
After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...
Emirates News Agency on MSN
Al Qassimi Hospital performs first heart rhythm disorders treatment using Volt PFA
The Cardiac Electrophysiology Department at Al Qassimi Hospital in Sharjah, which is part of the Emirates Health Services, has proudly carried out its first successful treatment for atrial ...
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...
Objective Patients with atrial fibrillation (AF) frequently have multiple comorbidities that increase the risk of hospitalisation and contribute to higher mortality. However, studies examining the ...
Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 22, Abbott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results